Loading…
Speciality Medicines (BSE 544738)₹155.00+4.06%Pharmaceuticals
Speciality Medicines is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 10.4 against a peer median of 16.8, and ROCE of 25.0% against a peer median of 13.1%, and latest-quarter sales growth of 45.2% against a peer median of 27.4%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sotac Pharmaceuticals | 143 | 25.0 | 13.1 | 10.3 | 0.64 | 0.1 | 101 | 6 | 27.6 | −50.0 | vs BSE 544738 |
| Kimia Biosciences | 142 | 19.2 | 25.0 | 53.6 | 1.97 | 0.0 | 115 | 7 | −12.1 | −39.3 | vs BSE 544738 |
| Auro Laboratories | 142 | 40.4 | 9.5 | 8.5 | 1.36 | 0.0 | 31 | 4 | 32.7 | 152.6 | vs BSE 544738 |
| Quest Laboratories | 142 | 9.5 | 17.9 | 16.8 | 0.08 | 0.0 | 112 | 15 | −30.3 | 48.2 | vs BSE 544738 |
| Panchsheel Organics | 141 | 13.0 | 10.0 | 7.9 | 0.04 | 3.0 | 107 | 11 | 9.5 | −46.5 | vs BSE 544738 |
| Par Drugs and Chemicals | 139 | 9.6 | 17.0 | 12.4 | 0.00 | 0.0 | 104 | 13 | 20.2 | 41.6 | vs BSE 544738 |
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | — |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 544738 |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs BSE 544738 |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs BSE 544738 |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs BSE 544738 |
| Peer median | 139 | 16.8 | 13.1 | 11.3 | 0.76 | 0.0 | 107 | 7 | 27.4 | 44.9 |
Listed companies closest to Speciality Medicines in Pharmaceuticals include Sotac Pharmaceuticals, Kimia Biosciences, Auro Laboratories, Quest Laboratories, Panchsheel Organics, Par Drugs and Chemicals, Parnax Lab, Bal Pharma.
Sotac Pharmaceuticals, with a market cap of ₹143 Cr.
Speciality Medicines trades at a P/E of 10.4; the median of its peer set is 16.8. A P/E above or below the median is a description, not a judgement on value.
Speciality Medicines' return on capital employed is 25.0%, above the peer median of 13.1%.